Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06EIJ
|
|||
| Former ID |
DIB004992
|
|||
| Drug Name |
RFT-5.dgA
|
|||
| Synonyms |
IMTOX-25; Anti-CD25 antibody, University of Texas Southwestern Medical Center; Immunotoxin (cancer), University of Texas Southwestern Medical Center/ Cologne University
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 2 | [1] | |
| Company |
University of Texas Southwestern Medical Center
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00667017) RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma. U.S. National Institutes of Health. | |||
| REF 2 | Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma. Ann Oncol. 2003 May;14(5):729-36. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.